tiprankstipranks
Trending News
More News >
Immunome (IMNM)
NASDAQ:IMNM
US Market

Immunome (IMNM) Ownership - Who Owns Immunome?

Compare
426 Followers

Immunome (IMNM) Ownership Overview

4.91%25.08%10.63%11.15%48.23%
10.63% Other Institutional Investors
11.15% ETFs
48.23% Public Companies and
Individual Investors
The ownership structure of Immunome (IMNM) stock is a mix of institutional, retail, and individual investors. Approximately 46.86% of the company’s stock is owned by Institutional Investors, 4.91% is owned by Insiders, and 48.23% is owned by Public Companies and Individual Investors.
The ownership structure of Immunome (IMNM) stock is a mix of institutional, retail, and individual investors. Approximately 35.71% of the company’s stock is owned by Institutional Investors, 4.91% is owned by Insiders, and 11.15% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Dec 30, 2025
xxxxxxxxxxxxx
$100018
Dec 22, 2025
xxxxxxxxxxxxx
$149053
Dec 22, 2025
xxxxxxxxxxxxx
$204900
Dec 18, 2025
xxxxxxxxxxxxx
$999987

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2025
xxxxxxxxxxxxx
$189754
Dec 31, 2025
xxxxxxxxxxxxx
$3756014
Dec 31, 2025
xxxxxxxxxxxxx
$33839549
Dec 31, 2025
xxxxxxxxxxxxx
$79604321

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
6,190,237Institution5.61%138,908,918
5,129,034Institution4.65%115,095,523
4,685,441Institution4.25%105,141,296
4,165,824Insider3.78%93,481,091
3,699,427Institution3.35%83,015,142
3,551,905Institution3.22%79,704,748
3,113,188Institution2.82%69,859,939
2,840,465Institution2.57%63,740,035
2,674,700Institution2.42%60,020,268
2,217,282Institution2.01%49,755,808

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
6,190,237Institution5.61%138,908,918
3,551,905Institution3.22%79,704,748
3,113,188Institution2.82%69,859,939
2,840,465Institution2.57%63,740,035
2,674,700Institution2.42%60,020,268
2,098,664Institution1.90%47,094,020
1,574,037Institution1.43%35,321,390
931,300Institution0.84%20,898,372
839,542Institution0.76%18,839,322
814,292Institution0.74%18,272,712

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
3,125,923Institution2.83%67,144,826
2,306,937Institution2.09%51,767,666
2,088,042Institution1.89%46,855,662
1,119,587Institution1.01%24,048,729
783,871Institution0.71%17,590,065
499,353Institution0.45%11,205,481
460,537Institution0.42%9,892,335
283,249Institution0.26%6,084,189
256,954Institution0.23%5,766,048
177,434Institution0.16%4,153,730

FAQ

Who Owns Immunome (IMNM)?
According to the latest TipRanks data, approximately 10.63% of the company's stock is held by institutional investors, 4.91% is held by insiders, and 48.23% is held by retail investors.
    What percentage of Immunome (IMNM) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 10.63% of Immunome (IMNM) stock is held by institutional investors.
      What percentage of Immunome (IMNM) stock is held by retail investors?
      According to the latest TipRanks data, approximately 48.23% of Immunome (IMNM) stock is held by retail investors.
        Who owns the most shares of Immunome (IMNM)?
        Fidelity Mt. Vernon Street Trust owns the most shares of Immunome (IMNM).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.